These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8805938)

  • 1. Paclitaxel in the salvage treatment of Hodgkin's disease and non-Hodgkin's lymphoma.
    Hopfinger G; Heinz R; Pfeilstöcker M; Schlögl E; Waldner R; Pittermann E
    Ann Oncol; 1996 Apr; 7(4):423-4. PubMed ID: 8805938
    [No Abstract]   [Full Text] [Related]  

  • 2. Vinorelbine in the treatment of lymphoma.
    Rule S; Tighe M; Davies S; Johnson S
    Hematol Oncol; 1998 Sep; 16(3):101-5. PubMed ID: 10235068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study on the use of outpatient fractionated ifosfamide, carboplatin and etoposide (ICE) and pegfilgrastim as a salvage and mobilizing regimen for relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma.
    George B; Benson W; Hertzberg MS
    Bone Marrow Transplant; 2012 Jul; 47(7):1001-2. PubMed ID: 22002487
    [No Abstract]   [Full Text] [Related]  

  • 4. Activity of single agent vinorelbine in pretreated non-Hodgkin's lymphoma.
    Balzarotti M; Santoro A; Tondini C; Fornier M; Bonadonna G
    Ann Oncol; 1996 Nov; 7(9):970-2. PubMed ID: 9006750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-based treatment of lymphoma.
    Younes A
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):123-8. PubMed ID: 10190794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I/II trial of paclitaxel for non-Hodgkin's lymphoma followed by paclitaxel plus quinine in drug-resistant disease.
    Miller TP; Chase EM; Dorr R; Dalton WS; Lam KS; Salmon SE
    Anticancer Drugs; 1998 Feb; 9(2):135-40. PubMed ID: 9510499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose cyclophosphamide followed by autologous peripheral blood progenitor cell transplantation improves the salvage treatment for persistent or sensitive relapsed malignant lymphoma.
    Baldissera RC; Aranha JF; Oliveira GB; Vigorito AC; Eid KA; Miranda EC; De Souza CA
    Braz J Med Biol Res; 2002 Jan; 35(1):49-57. PubMed ID: 11743614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment side effects. Case 2. Toxic, epidermal, necrolysis-like reaction associated with docetaxel chemotherapy.
    Dourakis SP; Sevastianos VA; Alexopoulou A; Deutsch M; Stavrianeas N
    J Clin Oncol; 2002 Jul; 20(13):3030-2. PubMed ID: 12089234
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma.
    Laport GF; Williams SF
    Semin Oncol; 1998 Aug; 25(4):503-17. PubMed ID: 9728600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mobilization of peripheral-blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin's lymphoma, and Hodgkin's disease.
    Copelan EA; Ceselski SK; Ezzone SA; Lasky LC; Penza SL; Bechtel TP; Klein JL; Hehmeyer DM; Scholl MD; Marshall DD; Elder PJ; Risley GL; Avalos BR
    J Clin Oncol; 1997 Feb; 15(2):759-65. PubMed ID: 9053502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
    Josting A; Reiser M; Rueffer U; Salzberger B; Diehl V; Engert A
    J Clin Oncol; 2000 Jan; 18(2):332-9. PubMed ID: 10637247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of docetaxel in non-Hodgkin's lymphomas: a study of the Cancer and Leukemia Group B.
    Budman DR; Petroni GR; Johnson JL; Cooper MR; Schlossman DM; Barcos M; Peterson BA
    J Clin Oncol; 1997 Oct; 15(10):3275-9. PubMed ID: 9336365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy as salvage treatment in patients with Hodgkin's disease or non-Hodgkin's lymphoma relapsing after initial chemotherapy.
    Kirkove C; Timothy AR
    Hematol Oncol; 1991; 9(3):163-7. PubMed ID: 1937407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage combination chemotherapy with cisplatinum, etoposide and bleomycin in refractory non-Hodgkin's lymphomas.
    Comella P; Abate G; Di Finizio G; Fiore M; Zarrilli D
    J Chemother; 1989 Jul; 1(4 Suppl):1262-3. PubMed ID: 16312858
    [No Abstract]   [Full Text] [Related]  

  • 15. Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin's lymphoma and Hodgkin's disease.
    Hertzberg MS; Crombie C; Benson W; Taper J; Gottlieb D; Bradstock KF
    Ann Oncol; 2003; 14 Suppl 1():i11-6. PubMed ID: 12736225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifosfamide, epirubicin and etoposide (IEV) therapy in relapsed and refractory high-grade non-Hodgkin's lymphoma and Hodgkin's disease.
    Zinzani PL; Barbieri E; Visani G; Gherlinzoni F; Perini F; Neri S; Bendandi M; Ammendolia I; Salvucci M; Babini L
    Haematologica; 1994; 79(6):508-12. PubMed ID: 7534744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of fludarabine and paclitaxel in non-Hodgkin's lymphoma.
    Abbasi MR; Sparano JA; Sarta C; Wiernik PH
    Med Oncol; 2003; 20(1):53-8. PubMed ID: 12665685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Standard treatment of malignant lymphoma (Hodgkin's and non-Hodgkin's lymphoma)].
    Hotta T
    Nihon Naika Gakkai Zasshi; 2001 Jun; 90(6):997-1002. PubMed ID: 11460390
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-term follow-up of Hodgkin's disease and unfavorable type of non-Hodgkin's lymphoma].
    Sampi K; Maseki N; Sakurai M; Hattori M
    Rinsho Ketsueki; 1988 Feb; 29(2):144-8. PubMed ID: 3385941
    [No Abstract]   [Full Text] [Related]  

  • 20. Rituximab salvage following relapse after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma.
    Milojkovic D; Mijovic A; Taylor CG; Mufti GJ; Pagliuca A
    Br J Haematol; 2000 Sep; 110(4):1013-4. PubMed ID: 11054097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.